The Evolving Role of Hospital and Community Pharmacist in Post-COVID-19 Healthcare Delivery in Bangladesh: A Survey-Based Analysis

Md. Maniruzzaman¹, Md. Rakib Rased Rana², Md Mizan³, Md. Sakibul Hasan⁴, Md. Nasim ⁴, Saiful Islam³, Jannatul Ferdush Easha mony³, Farjana Akter Shimo³, Miss Nuzhat Tasnim², Md Nahid Hasan²

This study highlights post-pandemic roles of Bangladeshi pharmacists, emphasizing their evolving contributions to healthcare access, management, and therapeutic decision-making.

Abstract

Background: The COVID-19 pandemic has profoundly reshaped global healthcare systems, particularly in developing countries like Bangladesh and India. This review highlights the evolving role of community pharmacists in post-pandemic healthcare delivery, emphasizing their contributions to public health, medication management, and self-medication guidance. It also reflects on the challenges of expanding their professional scope amidst limited resources and public misconceptions. Methods: A cross-sectional survey was conducted from January to August 2023 to assess the roles, responsibilities, and professional backgrounds of pharmacists across clinics, private, and government hospitals in Bangladesh. Data were collected anonymously via email and social media, validated through professional credentials, and analyzed using SPSS version 25. Results: The findings revealed that government hospital pharmacists predominantly held diplomas, while clinics and private hospitals employed more graduates. Participants reported increased workloads, logistical barriers, and heightened responsibilities during the pandemic. Pharmacists with postgraduate education or more than 12 years of experience significantly contributed to COVID-19 response efforts, including drug counseling, therapeutic monitoring, and participation in research. Conclusion: The study underscores the critical yet underrecognized role of community pharmacists in public health during the pandemic recovery phase. Their academic qualifications and experience were essential in sustaining healthcare delivery, managing drug supply, and supporting patient care. Policymakers must strengthen their integration into the healthcare system through regulatory support and professional recognition.

Keywords: Community pharmacy, healthcare workforce, drug management, self-medication, COVID-19, Bangladesh.

References

Balla, M., Merugu, G. P., Patel, M., Koduri, N. M., Gayam, V., Adapa, S., Naramala, S., & Konala, V. M. (2020). COVID-19, modern pandemic: A systematic review from front-line health care providers’ perspective. Journal of Clinical Medicine Research, 12(5), 215–229. https://doi.org/10.14740/jocmr4142

Behzadifar, M., Ghanbari, M. K., Bakhtiari, A., Behzadifar, M., & Bragazzi, N. L. (2020). Ensuring adequate health financing to prevent and control the COVID-19 in Iran. International Journal for Equity in Health, 19, 61. https://doi.org/10.1186/s12939-020-01181-9

Carter, B. L. (2016). Evolution of clinical pharmacy in the US and future directions for patient care. Drugs & Aging, 33(3), 169–177. https://doi.org/10.1007/s40266-016-0349-2

Cheong, M. W. L. (2020). "To be or not to be in the ward": The impact of COVID-19 on the role of hospital-based clinical pharmacists—A qualitative study. Journal of the American College of Clinical Pharmacy, 3(8), 1458–1463. https://doi.org/10.1002/jac5.1315

Chin, T. W., Chant, C., & Tanzini, R. (2004). Severe acute respiratory syndrome (SARS): The pharmacist’s role. Pharmacotherapy, 24(8), 705–712. https://doi.org/10.1592/phco.24.8.705.36063

Chui, W. K., & Li, S. C. (2005). Advice-giving on self-medication: Perspectives of community pharmacists and consumers in Singapore. Journal of Clinical Pharmacy and Therapeutics, 30(3), 225–231.

Covington, T. R. (2002). The pharmacist as nonprescription drug therapy manager: Let’s seize the opportunity. Journal of the American Pharmacists Association, 42(3), 518–519.

Ghibu, S., Juncan, A. M., Rus, L. L., Frum, A., Dobrea, C. M., Chis, A. A., Gligor, F. G., & Morgovan, C. (2021). The particularities of pharmaceutical care in improving public health service during the COVID-19 pandemic. International Journal of Environmental Research and Public Health, 18(18), 9776. https://doi.org/10.3390/ijerph18189776

Hoti, K., Jakupi, A., Hetemi, D., Raka, D., Hughes, J., & Desselle, S. (2020). Provision of community pharmacy services during COVID-19 pandemic: A cross-sectional study of community pharmacists' experiences with preventative measures and sources of information. International Journal of Clinical Pharmacy, 42(4), 1197–1206. https://doi.org/10.1007/s11096-020-01078-1

John, C. (2018). The changing role of the pharmacist in the 21st century. Pharmaceutical Journal, 300. https://doi.org/10.1211/PJ.2018.20204131

Kennedy, M. J. (2018). Personalized medicines—Are pharmacists ready for the challenge? Integrated Pharmacy Research and Practice, 7, 113–123. https://doi.org/10.2147/IPRP.S133083

Klepser, M. E., Klepser, D. G., Dering-Anderson, A., Morse, J. A., Smith, J. K., & Klepser, S. A. (2016). Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness. Journal of the American Pharmacists Association, 56(1), 14–21. https://doi.org/10.1016/j.japh.2015.11.008

Martins, A. P., da Costa Miranda, A., Mendes, Z., Soares, M. A., Ferreira, P., & Nogueira, A. (2002). Self-medication in a Portuguese urban population: A prevalence study. Pharmacoepidemiology and Drug Safety, 11(5), 409–414.

Nussbaumer-Streit, B., Mayr, V., Dobrescu, A. I., Chapman, A., Persad, E., Klerings, I., Wagner, G., Siebert, U., Christof, C., Zachariah, C., et al. (2020). Quarantine alone or in combination with other public health measures to control COVID-19: A rapid review. Cochrane Database of Systematic Reviews, 4, CD013574. https://doi.org/10.1002/14651858.CD013574

Paudyal, V., Cadogan, C., Fialová, D., Henman, M. C., Hazen, A., Okuyan, B., Lutters, M., & Stewart, D. (2021). Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries. Research in Social and Administrative Pharmacy, 17(8), 1507–1517. https://doi.org/10.1016/j.sapharm.2020.11.017

Skolaut, M. W. (1980). Moving toward the 21st century. American Journal of Health-System Pharmacy, 37(3), 355–358. https://doi.org/10.1093/ajhp/37.3.355

Song, Z., Hu, Y., Zheng, S., Yang, L., & Zhao, R. (2021). Hospital pharmacists' pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Research in Social and Administrative Pharmacy, 17(1), 2027–2031. https://doi.org/10.1016/j.sapharm.2020.03.027

Strand, M. A., Bratberg, J., Eukel, H., Hardy, M., & Williams, C. (2020). Community pharmacists' contributions to disease management during the COVID-19 pandemic. Preventing Chronic Disease, 17, E69. https://doi.org/10.5888/pcd17.200317

Tisman, A. (2010). The rising tide of OTC in Europe: Trends, challenges and new potential in a rapidly evolving market. IMS Health. Retrieved January 23, 2015, from http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Healthcare/Healthcare%20Solutions/Consumers/The_Rising_Tide_Of_OTC_Europe.pdf

Toklu, H. Z., & Hussain, A. (2013). The changing face of pharmacy practice and the need for a new model of pharmacy education. Journal of Young Pharmacists, 5(2), 38–40. https://doi.org/10.1016/j.jyp.2012.09.001

Traulsen, J. M., & Druedahl, L. C. (2018). Shifting perspectives—Planning for the future of the pharmacy profession taking current labor market trends into consideration. Research in Social and Administrative Pharmacy, 14(11), 1189–1194. https://doi.org/10.1016/j.sapharm.2018.02.006

Urick, B. Y., & Meggs, E. V. (2019). Towards a greater professional standing: Evolution of pharmacy practice and education, 1920–2020. Pharmacy, 7(3), 98. https://doi.org/10.3390/pharmacy7030098

Youssef, E., & Wright, D. (2020). Pharmacogenomic testing and its future in community pharmacy. Pharmaceutical Journal, 304, 52–57.

Zheng, S. Q., Yang, L., Zhou, P. X., Li, H. B., Liu, F., & Zhao, R. S. (2021). Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Research in Social and Administrative Pharmacy, 17(1), 1819–1824. https://doi.org/10.1016/j.sapharm.2020.03.012